Taiwan Cabinet Approves WTO TRIPS Amendment
This article was originally published in PharmAsia News
Taiwan's Cabinet gave its approval of intellectual property rights regulations adopted by the World Trade Organization. The WTO amendment remains to be ratified by the end of next year by Taiwan's legislature. The Trade-Related Aspects of Intellectual Property Rights allows countries without makers of generics drugs to import generics under a well-defined compulsory licensing procedure. (Click here for more
You may also be interested in...
SHANGHAI - Merck KGaA and Taiwan's Development Center for Biotechnology announced Oct. 29 the opening of Merck's Asian Technology and Training Center in Taiwan
CV Defense, the second launch in the firm’s new immune-support line (without cannabidiol), is built around palmitoylethanolamide and other nutrients and botanicals to “optimize immune response.” CV Sciences touts the immunity range as complementary to its PlusCBD brand, which is in the process of rolling out dozens of new products in updated packaging.
Public Company Edition: Codiak, Kiromic, Aligos and Opthea have fallen below their initial public offering values, while Tarsus and Praxis are trading higher. Also, 5AM, MPM and Cormorant took biotech SPACs public and Evotec led recent non-IPO financings with a €250m private placement.